KINSLEIGH SHAH: Open Payments
NPI 1740934017 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 41 payments from 16 companies in 2025. Trend: 2023 $1,168 · 2024 $870 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $182 |
| Regeneron Healthcare Solutions, Inc. | 6 | $153 |
| UCB, Inc. | 4 | $127 |
| PFIZER INC. | 6 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $43 |
| Organon LLC | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $35 |
Products named: DUPIXENT, Bimzelx, CIBINQO, ILUMYA, TREMFYA, HADLIMA, NEMLUVIO, Rhapsido.
Industry payments across NC — which companies pay providers there.
